Annual Non Current Assets
$8.45 M
+$6.45 M+322.91%
December 31, 2023
Summary
- As of February 8, 2025, XLO annual long term assets is $8.45 million, with the most recent change of +$6.45 million (+322.91%) on December 31, 2023.
- During the last 3 years, XLO annual non current assets has risen by +$7.60 million (+889.48%).
- XLO annual non current assets is now at all-time high.
Performance
XLO Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$11.35 M
-$516.00 K-4.35%
September 30, 2024
Summary
- As of February 8, 2025, XLO quarterly long term assets is $11.35 million, with the most recent change of -$516.00 thousand (-4.35%) on September 30, 2024.
- Over the past year, XLO quarterly non current assets has dropped by -$1.45 million (-11.33%).
- XLO quarterly non current assets is now -27.84% below its all-time high of $15.73 million, reached on December 31, 2020.
Performance
XLO Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
XLO Non Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +322.9% | -11.3% |
3 y3 years | +889.5% | -11.3% |
5 y5 years | +1388.5% | -11.3% |
XLO Non Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +988.5% | -27.0% | at low |
5 y | 5-year | at high | +988.5% | -27.8% | at low |
alltime | all time | at high | >+9999.0% | -27.8% | at low |
Xilio Therapeutics Non Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $11.35 M(-4.3%) |
Jun 2024 | - | $11.87 M(-11.6%) |
Mar 2024 | - | $13.42 M(+4.9%) |
Dec 2023 | $57.67 M(+280.7%) | $12.80 M(-4.2%) |
Sep 2023 | - | $13.36 M(-4.1%) |
Jun 2023 | - | $13.93 M(-4.1%) |
Mar 2023 | - | $14.53 M(-1.0%) |
Dec 2022 | $15.15 M | $14.67 M(-2.9%) |
Sep 2022 | - | $15.10 M(-0.1%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $15.12 M(-0.9%) |
Mar 2022 | - | $15.27 M(-1.8%) |
Dec 2021 | $12.52 M(-26.0%) | $15.54 M(+2.6%) |
Sep 2021 | - | $15.15 M(-1.8%) |
Jun 2021 | - | $15.44 M(-1.8%) |
Dec 2020 | $16.93 M(+210.3%) | $15.73 M |
Dec 2019 | $5.46 M(+145.0%) | - |
Dec 2018 | $2.23 M(-7.0%) | - |
Dec 2017 | $2.39 M(-17.3%) | - |
Dec 2016 | $2.89 M | - |
FAQ
- What is Xilio Therapeutics annual long term assets?
- What is the all time high annual non current assets for Xilio Therapeutics?
- What is Xilio Therapeutics annual non current assets year-on-year change?
- What is Xilio Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Xilio Therapeutics?
- What is Xilio Therapeutics quarterly non current assets year-on-year change?
What is Xilio Therapeutics annual long term assets?
The current annual non current assets of XLO is $8.45 M
What is the all time high annual non current assets for Xilio Therapeutics?
Xilio Therapeutics all-time high annual long term assets is $8.45 M
What is Xilio Therapeutics annual non current assets year-on-year change?
Over the past year, XLO annual long term assets has changed by +$6.45 M (+322.91%)
What is Xilio Therapeutics quarterly long term assets?
The current quarterly non current assets of XLO is $11.35 M
What is the all time high quarterly non current assets for Xilio Therapeutics?
Xilio Therapeutics all-time high quarterly long term assets is $15.73 M
What is Xilio Therapeutics quarterly non current assets year-on-year change?
Over the past year, XLO quarterly long term assets has changed by -$1.45 M (-11.33%)